As sites of action for drugs used to treat schizophrenia and Parkinson's
disease, dopamine receptors are among the most validated drug targets
for neuropsychiatric disorders. Dopamine receptors are also drug targets
or potential targets for other disorders such as substance abuse,
depression, Tourette's syndrome, and attention deficit hyperactivity
disorder. Updated from the successful first edition, "The Dopamine
Receptors" serves as a reference work on dopamine receptors while also
highlighting the areas of research that are most active today. To
achieve this goal, authors have written chapters that set a broad area
of research in its historical context, rather than focusing on the
research output of their own laboratories.
